All data are based on the daily closing price as of July 12, 2024
j

JW Pharmaceutical

001060.KO
25.11 USD
0.46
+1.87%

Overview

Last close
25.11 usd
Market cap
577.23M usd
52 week high
35.83 usd
52 week low
14.35 usd
Target price
33.03 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.9548
Price/Book Value
2.7114
Enterprise Value
617.36M usd
EV/Revenue
1.0618
EV/EBITDA
8.834

Key financials

Revenue TTM
550.16M usd
Gross Profit TTM
209.62M usd
EBITDA TTM
89.70M usd
Earnings per Share
N/A usd
Dividend
0.29 usd
Total assets
488.31M usd
Net debt
67.95M usd

About

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
  • Symbol
    001060.KO
  • Exchange
    KO
  • Isin
    KR7001060003
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Young-Sub Shin
  • Headquarter
    Gwacheon-si
  • Web site
    https://www.jw-pharma.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top